GM has filed to trademark the term Infinite Route for a second time. The term may be used in conjunction with the automaker's ...

The rare bipartisan vote, 231-195, marks the first time the House has voted to overturn an executive order from President ...

ESTERO, FL / ACCESS Newswire / December 4, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology, ...

NeXtGen Biologics is pleased to report that the USPTO declined to initiate Inter Partes Review ("IPR"), following the filing by RegenX Science of two IPR Petitions in February 2025 requesting the ...

The United States Patent and Trademark Office (“USPTO” or the “Office”) released several memoranda[1] the week of December 1, 2025, providing ...

But if X owner Elon Musk doesn’t see the value in the name, a startup called Operation Bluebird apparently does. The company ...

The United States Patent and Trademark Office (USPTO) has issued an advance notice of change to the Manual of Patent Examining Procedure (MPEP) ...

The move doesn’t guarantee a new electric Buick in the U.S ., but it strongly hints that the brand is weighing its options.

This research led to Balu-Iyer founding the Buffalo-based company Immune Modulatory Therapies LLC in 2019. His UB co-founders ...

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on a patent grant, testing ...

NeXtGen is looking ahead to the expansion of its patent portfolio and product offerings. Future indications being explored include use in plastic surgery, orthopedic (tendon and bone), cardiovascular, ...

The newly granted U.S. patent, No. 12,492,178, includes claims to the drug substance of EMP-01, and is expected to provide exclusivity through 2043. This patent identifies a highly-crystalline, ...